
Assign tiers of clinical significance (AMP/ASCO/CAP framework) to somatic CNAs
Source:R/variant_classification.R
assign_variant_tiers_cna.RdFunction that assigns tiers of clinical significance (AMP/ASCO/CAP framework) to somatic CNAs based on biomarker evidence items. The function considers the strength of evidence (evidence levels) and the match between biomarker site and primary site of query tumor. The function also considers gene properties - oncogenes and tumor suppressor genes - which are used to assign tier 3 status to variants with uncertain clinical significance.
Usage
assign_variant_tiers_cna(
primary_site = "Any",
biomarker_mapping_confidence = "medium",
var_df = NULL,
etype_for_tiering = c("predictive"),
biomarker_items = NULL
)Arguments
- primary_site
primary tumor site of query tumor (e.g. 'Lung', 'Breast', 'Any')
- biomarker_mapping_confidence
confidence level of variant-biomarker mapping resolution (e.g. 'high' or 'medium')
- var_df
data frame with somatic CNAs
- etype_for_tiering
evidence type(s) to consider for tier classification (e.g. 'predictive', 'prognostic', 'diagnostic')
- biomarker_items
data frame with biomarker evidence items